Patent details

EP1303258 Title: NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE

Basic Information

Publication number:
EP1303258
PCT Application Number:
PCT/SE/2001/001606
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019520717
PCT Publication Number:
WO/2002/003958
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE
French Title of Invention:
NOUVELLE PREPARATION EN AEROSOL CONTENANT UNE MOLECULE FLUOREE POLAIRE
German Title of Invention:
NEUE AEROSOLFORMULIERUNGEN EIN POLARES FLUORINIERTES MOLEKÜL ENTHALTEND
SPC Number:

Dates

Filing date:
10/07/2001
Grant date:
11/10/2006
EP Publication Date:
11/10/2006
PCT Publication Date:
17/01/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/04/2003
EP B1 Publication Date:
11/10/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/07/2012
Expiration date:
10/07/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/07/2001
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN MICHEL
From:
20/12/2006
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

Name:
ROGUEDA Philippe, AstraZeneca R&D Charnwood
Address:
United Kingdom (GB)

Priority

Priority Number:
0016876
Priority Date:
11/07/2000
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 9/12;
Filing date Document type Number of pages